vs
Side-by-side financial comparison of Organon & Co. (OGN) and WEIBO Corp (WB). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs -13.6%, a 49.3% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
OGN vs WB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.3B |
| Net Profit | $-205.0M | $458.3M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 29.1% |
| Net Margin | -13.6% | 35.7% |
| Revenue YoY | -5.3% | — |
| Net Profit YoY | -288.1% | — |
| EPS (diluted) | $-0.78 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $841.7M | ||
| Q1 25 | $1.5B | $396.9M | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $833.4M | ||
| Q1 24 | $1.6B | $395.5M |
| Q4 25 | $-205.0M | — | ||
| Q3 25 | $160.0M | $458.3M | ||
| Q2 25 | $145.0M | $234.8M | ||
| Q1 25 | $87.0M | $108.1M | ||
| Q4 24 | $109.0M | — | ||
| Q3 24 | $359.0M | $297.4M | ||
| Q2 24 | $195.0M | $164.6M | ||
| Q1 24 | $201.0M | $51.1M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | — | ||
| Q3 25 | 15.2% | 29.1% | ||
| Q2 25 | 14.4% | 30.4% | ||
| Q1 25 | 6.7% | 27.8% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 13.1% | 29.0% | ||
| Q2 24 | 14.6% | 28.2% | ||
| Q1 24 | 14.5% | 25.2% |
| Q4 25 | -13.6% | — | ||
| Q3 25 | 10.0% | 35.7% | ||
| Q2 25 | 9.1% | 27.9% | ||
| Q1 25 | 5.8% | 27.2% | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 22.7% | 22.9% | ||
| Q2 24 | 12.1% | 19.8% | ||
| Q1 24 | 12.4% | 12.9% |
| Q4 25 | $-0.78 | — | ||
| Q3 25 | $0.61 | — | ||
| Q2 25 | $0.56 | — | ||
| Q1 25 | $0.33 | — | ||
| Q4 24 | $0.42 | — | ||
| Q3 24 | $1.38 | — | ||
| Q2 24 | $0.75 | — | ||
| Q1 24 | $0.78 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $1.1B |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $3.9B |
| Total Assets | $12.9B | $6.9B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | — | ||
| Q3 25 | $672.0M | $1.1B | ||
| Q2 25 | $599.0M | $1.2B | ||
| Q1 25 | $547.0M | $1.2B | ||
| Q4 24 | $675.0M | — | ||
| Q3 24 | $763.0M | — | ||
| Q2 24 | $704.0M | $1.9B | ||
| Q1 24 | $575.0M | $2.1B |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | — | ||
| Q3 25 | $906.0M | $3.9B | ||
| Q2 25 | $733.0M | $3.6B | ||
| Q1 25 | $542.0M | $3.5B | ||
| Q4 24 | $472.0M | — | ||
| Q3 24 | $493.0M | — | ||
| Q2 24 | $144.0M | $3.4B | ||
| Q1 24 | $48.0M | $3.3B |
| Q4 25 | $12.9B | — | ||
| Q3 25 | $13.6B | $6.9B | ||
| Q2 25 | $13.5B | $6.5B | ||
| Q1 25 | $13.2B | $6.7B | ||
| Q4 24 | $13.1B | — | ||
| Q3 24 | $12.8B | — | ||
| Q2 24 | $12.2B | $7.1B | ||
| Q1 24 | $11.9B | $7.3B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | — |
| Free Cash FlowOCF − Capex | $96.0M | — |
| FCF MarginFCF / Revenue | 6.4% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | — | ||
| Q3 25 | $264.0M | — | ||
| Q2 25 | $220.0M | — | ||
| Q1 25 | $75.0M | — | ||
| Q4 24 | $390.0M | — | ||
| Q3 24 | $141.0M | — | ||
| Q2 24 | $332.0M | — | ||
| Q1 24 | $76.0M | — |
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 2.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
